Emory University’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Emory University’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-148,628	Closed	-$2.64M	–	53
2018 Q3	$2.64M	Sell	148,628 -56,667	-28%	-$973K	1.73%	19
2018 Q2	$2.83M	Buy	+205,295	New	+$2.44M	1.88%	12

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Emory University's ECYT Position: Q4 2018 in Review

Emory University sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 148,628 shares — an estimated $2.64M sold.

Emory University first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $2.83M in Q2 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Emory University reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Emory University sold 148,628 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $2.64M.
Emory University first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Emory University's Endocyte, Inc. Common Stock position peaked at $2.83M in Q2 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Emory University's 13F filing for Q4 2018, filed 12 Feb 2019.